Achievaa Pharmaceutical India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.98 M
About Achievaa Pharmaceutical India
Achievaa Pharmaceutical India Private Limited (APIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2006 and has a history of 18 years and four months. Its registered office is in Namakkal, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.98 M.
Adaikalam Shanmugam, Shanmugam Aanandha, and Shanmugam Anandkumar serve as directors at the Company.
Company Details
-
Location
Namakkal, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232TZ2006PTC013132
-
Company No.
013132
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Oct 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Achievaa Pharmaceutical India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shanmugam Anandkumar
|
Managing Director | 09-Oct-2006 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Adaikalam Shanmugam
|
Director | 09-Oct-2006 | Current |
|
Shanmugam Aanandha
|
Director | 09-Oct-2006 | Current |
Financial Performance of Achievaa Pharmaceutical India.
Achievaa Pharmaceutical India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Achievaa Pharmaceutical India?
In 2017, Achievaa Pharmaceutical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.98 M
₹0
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2021 | City Union Bank Limited | ₹0.48 M | Open |
| 10 Oct 2012 | City Union Bank Limited | ₹2.50 M | Open |
How Many Employees Work at Achievaa Pharmaceutical India?
Unlock and access historical data on people associated with Achievaa Pharmaceutical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Achievaa Pharmaceutical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Achievaa Pharmaceutical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.